These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35936366)

  • 1. Effects of Carvedilol on Blood Pressure, Blood Sugar, and Blood Lipids in Elderly Patients with Refractory Hypertension.
    Zhang W; Deng G; Hu J; Yan R; Hu J; Fan J
    Comput Math Methods Med; 2022; 2022():7889024. PubMed ID: 35936366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artist® tablets (carvedilol) for hypertensive patients in Japan: results of a drug use survey.
    Mori Y; Nishikawa Y; Iizuka T; Zenimura N; Matsumoto T; Hiramatsu K; Komiya M
    Drugs R D; 2011; 11(2):171-90. PubMed ID: 21679007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of folic acid combined with pravastatin on arteriosclerosis in elderly hypertensive patients with lacunar infarction.
    Li C; Bu X; Liu Y
    Medicine (Baltimore); 2021 Jul; 100(28):e26540. PubMed ID: 34260532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic and cardiovascular effects of carvedilol and atenolol in non-insulin-dependent diabetes mellitus and hypertension. A randomized, controlled trial.
    Giugliano D; Acampora R; Marfella R; De Rosa N; Ziccardi P; Ragone R; De Angelis L; D'Onofrio F
    Ann Intern Med; 1997 Jun; 126(12):955-9. PubMed ID: 9182472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effects of telmisartan and nifedipine gastrointestinal therapeutic system on blood pressure control, glucose metabolism, and the lipid profile in patients with type 2 diabetes mellitus and mild hypertension: a 12-month, randomized, double-blind study.
    Derosa G; Cicero AF; Bertone G; Piccinni MN; Fogari E; Ciccarelli L; Fogari R
    Clin Ther; 2004 Aug; 26(8):1228-36. PubMed ID: 15476904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of carvedilol on serum lipids in patients with essential hypertension.
    Goto Y; Tamachi H; Fusegawa Y; Nakaya N; Homma Y; Mikami M; Iori S; Yamazaki A
    J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S45-50. PubMed ID: 1721979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic and antihypertensive effects of moxonidine and moxonidine plus irbesartan in patients with type 2 diabetes mellitus and mild hypertension: a sequential, randomized, double-blind clinical trial.
    Derosa G; Cicero AF; D'Angelo A; Fogari E; Salvadeo S; Gravina A; Ferrari I; Fassi R; Fogari R
    Clin Ther; 2007 Apr; 29(4):602-10. PubMed ID: 17617283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind comparison of the effects of carvedilol and captopril on serum lipid concentrations in patients with mild to moderate essential hypertension and dyslipidaemia.
    Hauf-Zachariou U; Widmann L; Zülsdorf B; Hennig M; Lang PD
    Eur J Clin Pharmacol; 1993; 45(2):95-100. PubMed ID: 8223847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of long-term, low-dose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension: The Systolic Hypertension in the Elderly Program. SHEP Cooperative Research Group.
    Savage PJ; Pressel SL; Curb JD; Schron EB; Applegate WB; Black HR; Cohen J; Davis BR; Frost P; Smith W; Gonzalez N; Guthrie GP; Oberman A; Rutan G; Probstfield JL; Stamler J
    Arch Intern Med; 1998 Apr; 158(7):741-51. PubMed ID: 9554680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Better peridialytic blood pressure control using carvedilol in end stage renal disease patients on twice weekly maintenance hemodialysis.
    Chandra A; Rao N; Srivastava D; Mishra P
    Int Urol Nephrol; 2021 May; 53(5):1007-1014. PubMed ID: 33387227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of antioxidant property of carvedilol in mild to moderate hypertensive patients: A prospective open-label study.
    Ayashi S; Assareh AR; Jalali MT; Olapour S; Yaghooti H
    Indian J Pharmacol; 2016; 48(4):372-376. PubMed ID: 27756946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artist® tablets (carvedilol) for hypertensive patients in Japan: results of a long-term special survey.
    Iizuka T; Nishikawa Y; Mori Y; Zenimura N; Matsumoto T; Hiramatsu K; Komiya M
    Drugs R D; 2011; 11(2):191-205. PubMed ID: 21679008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic and antihypertensive effects of nebivolol and atenolol in normometabolic patients with mild-to-moderate hypertension.
    Pesant Y; Marc-Aurèle J; Bielmann P; Alaupovic P; Cartier P; Bichet D; Thibault G; Lupien PJ
    Am J Ther; 1999 May; 6(3):137-47. PubMed ID: 10423656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carvedilol and bisoprolol as initial therapy for adult hypertension without compelling indications.
    Kishi T; Fujii E
    Hypertens Res; 2019 Apr; 42(4):496-503. PubMed ID: 30948819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.
    Wong GW; Laugerotte A; Wright JM
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007449. PubMed ID: 26306578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of the coadministration of carvedilol and nifedipine sustained-release in the treatment of essential hypertension.
    Juttmann JR; de Vries Robles P; Venuti RP
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S134-7. PubMed ID: 1378141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of carvedilol versus metoprolol on endothelial function and oxidative stress in patients with type 2 diabetes mellitus.
    Bank AJ; Kelly AS; Thelen AM; Kaiser DR; Gonzalez-Campoy JM
    Am J Hypertens; 2007 Jul; 20(7):777-83. PubMed ID: 17586413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Results of ACES (Antihypertensive Combinations' Long Term Efficacy Comparing Study): Analysis of Metabolic Effects of Antihypertensive Combination Therapies.
    Nádházi Z; Dézsi CA
    Clin Drug Investig; 2016 Oct; 36(10):819-27. PubMed ID: 27405983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of carvedilol on serum lipids in hypertensive and normotensive subjects.
    Seguchi H; Nakamura H; Aosaki N; Homma Y; Mikami Y; Takahashi S
    Eur J Clin Pharmacol; 1990; 38 Suppl 2():S139-42. PubMed ID: 1974504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
    Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
    Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.